Bharat Biotech

BBV154: Intranasal Covid Vaccine Candidate By Bharat Biotech In Early Clinical Stage Of Development in India: Govt

BBV154, an intranasal vaccine candidate, being developed by Bharat Biotech, is in the early clinical stage of development in India. This has been announced by the Minister of State for Health Ashwini Choubey…

View Post

‘People Criticised Us’: Bharat Biotech Head On Covaxin’s Journey From March 2020

The chairman and managing director Krishna Ella addressed the criticism that the vaccine faced since the trial report was awaited, as Bharat Biotech published their interim efficacy report of phase…

View Post

Bharat Biotech’s Homegrown Covid-19 Vaccine Shows 81% Interim Efficacy

Bharat Biotech’s indigenously developed coronavirus vaccine Covaxin has shown an interim vaccine efficacy of 81% in late-stage clinical trials, the Indian company said on Wednesday. Covaxin was approved for restricted…

View Post

Latest News

Latest News

Tata Group In Talks To Launch Moderna COVID-19 Vaccine In India: Report

Tata Group’s healthcare venture is said to have begun initial negotiations with Moderna Inc for a collaboration to launch its COVID-19 vaccine in India, the Economic Times reported on Monday.…

View Post

Menu

Bharat Biotech

BBV154: Intranasal Covid Vaccine Candidate By Bharat Biotech In Early Clinical Stage Of Development in India: Govt

‘People Criticised Us’: Bharat Biotech Head On Covaxin’s Journey From March 2020

Bharat Biotech’s Homegrown Covid-19 Vaccine Shows 81% Interim Efficacy

Bharat Biotech, Ocugen Join Hands For Commercialization Of Covaxin In US

Unlike World, India Has Plenty Of Covid Shots But Only Few Willing To Take Them

Government Warns Of Action Against Those Spreading Rumours About Vaccines

Tata Group In Talks To Launch Moderna COVID-19 Vaccine In India: Report

Flesh-Eating Ulcer Cases Surge in Australia: Health Authorities Issue Warning

Epigamia Co-Founder Rohan Mirchandani Passes Away at 42 Due to Cardiac Arrest: Key Risk Factors and Warning Signs for Men in Their 40s

Does the 2022 H5N1 Virus Bind and Replicate Better in the Human Respiratory Tract? Here’s The Truth

Walking Speed Is An Indicator of Metabolic Health in Obese Individuals: Study Reveals

First-Ever Blood-Stage Malaria Vaccine Shows Promising Results in Phase IIb Trial

FDA Moves to Restrict Psychoactive Mushrooms Used in Edibles Amid Growing Concerns

Revolutionary CAR-T Cell Therapy Developed by AIIMS Researchers Offers New Hope for Multiple Myeloma Patients

Severe Strain of Bird Flu Spreading Rapidly: Is India at Risk of Another Pandemic?